Rappta Therapeutics raised €9.0M in a Series A round in Oct 2020. The company is based in Helsinki, Finland. Investors in the round: Novartis Venture Fund, Novo Holdings. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €9.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
